DGX: who owns it, and who’s predicted to buy next
Quest Diagnostics Inc · Health Care · on the Prior Moves forward board for 2026-09-30 at rank #90. Research, not investment advice.
Predicted to buy next quarter
3 tracked investors are included in the model-ranked expectations for DGX in 2026-09-30. This is a forecast about a later filing, not a confirmation that anyone has bought the security or a recommendation to do so.
- Lee Ainslie · Maverick
- Chuck Akre · Akre Capital
- Brad Gerstner · Altimeter
Strongest ranked investor signal: Lee Ainslie. No calibrated purchase probability is shown.
Currently disclosed holders
No investor in our tracked set discloses DGX in their latest 13F. The prediction above is a forward call, not a mirror of current holdings.
Mutual fund and ETF holders
415 US mutual funds and ETFs from 191 fund families reported a position in DGX for the quarter ending 2026-06-30. Against their own report a quarter earlier, 110 raised shares, 28 opened a new position, 157 cut and 20 sold out. Source: SEC Form N-PORT, which funds file about 60 days after quarter end. Share counts, not trades: a change can reflect fund inflows rather than a decision about DGX.
| Fund family | Funds | Share of fund-held shares |
|---|---|---|
| Vanguard Index Funds | 6 | 35.8% |
| Ishares Trust | 14 | 10.6% |
| John Hancock Funds Iii | 2 | 7.7% |
| Jpmorgan Trust Ii | 2 | 3.9% |
| T. Rowe Price Dividend Growth Fund, Inc. | 1 | 3.7% |
| Victory Portfolios | 2 | 3.5% |
| J.P. Morgan Fleming Mutual Fund Group, Inc. | 1 | 2.6% |
| Select Sector Spdr Trust | 1 | 2.6% |
The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.
See the full ranked board on top picks, how the PriorScore is built on how it works, the honest edge numbers on methodology, and the running accuracy on the prediction leaderboard. Forward quarter 2026-09-30, data as of 2026-10-16. Research, not investment advice, see the disclaimer.